Sitemap: Biotechnology

Advances in the Stem Cell Industry: The future impact of innovation, and an evaluation of the commercial landscape
Biomanufacturing Strategies: Market drivers, build-vs-buy decisions and opportunities in contract relationship management
Biomarkers - Advanced Technologies and Global Market (2009 - 2014)
Biopartnering Strategies: Maximizing returns from biotechnology deal-making
Biosimilars (2009 - 2014)
Biosimilars Series: Stakeholder Analysis
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
Biotech Financing in the Credit Crisis: Strategies for a radically altered landscape
Biotech for Wellness: Driving successful R&D and licensing in nutraceuticals through new business models and collaboration
Biotech M&A Strategies: Deal assessments, trends and future prospects
Biotechnology in Australia
Biotechnology in Australia - Industry Market Research Report
Biotechnology in the US
Biotechnology: Global Industry Guide
Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success
Commercial Opportunities from Biomarkers: Transforming drug discovery, clinical development and molecular diagnostics
Company Financials: Alkermes, Inc.
Company Financials: Anesiva, Inc.
Company Financials: Arqule, Inc.
Company Financials: BioMimetic Therapeutics, Inc.
Company Financials: BIOMS Medicals, Inc.
Company Financials: Biovail Corporation
Company Financials: Cougar Biotechnology, Inc.
Company Financials: Cypress Bioscience, Inc.
Company Financials: Dendreon Corporation
Company Financials: Discovery Laboratories, Inc.
Company Financials: Edwards Lifesciences Corporation
Company Financials: Exelixis
Company Financials: Genentech, Inc.
Company Financials: Genmab A/S
Company Financials: Genomic Health
Company Financials: Genta Incorporated
Company Financials: Genzyme Corporation
Company Financials: Gilead Sciences, Inc.
Company Financials: GTC Biotherapeutics, Inc.
Company Financials: Human Genome Sciences, Inc.
Company Financials: Illumina, Inc.
Company Financials: Martek Biosciences Corporation
Company Financials: Maxygen, Inc.
Company Financials: MDRNA, Inc.
Company Financials: MorphoSys AG
Company Financials: Neurocrine Biosciences, Inc.
Company Financials: Sangamo Biosciences, Inc.
Company Financials: Seattle Genetics, Inc.
Company Financials: SuperGen, Inc.
DNA Sequencing In Drug Discovery: Market outlook for applications, tools and services, and 40 company profiles
Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
Global Biomaterial Market (2009 - 2014)
Global Biotechnology
Global Biotechnology
Global Top 10 Biotechnology Companies Industry, Financial and SWOT Analysis
Global Top 10 Biotechnology Companies - Industry, Financial and SWOT Analysis
Innovations in Bioinformatics: Emerging tools for drug discovery and development
MarketWatch: Biotechnology
Opportunities in Stem Cell Research and Commercialization: Technology advances, regulatory impact and key players
Outlook for RNAi, 2007: siRNA and miRNA in biology, diagnostics and therapeutics
Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
The Convergence of Biomarkers and Diagnostics: Therapy area analyses, key products and future trends
The Fastest Growing Biotechnology Companies: Growth strategies, comparative analyses and company profiles
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery
The Future of Biosimilars - Market Forecasts to 2015, Opportunity Analysis and Regulatory Pathways
The Future of Biosimilars: Key opportunities & emerging therapies
The Future of the Biodefense Industry: Regulation, funding opportunities & company profiles
The Global Bioinformatics Market: Market size, forecasts and company profiles
The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline